76 results on '"Blessmann, M."'
Search Results
2. Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers.
- Author
-
Melling N, Grass J, Reeh M, Tachezy M, Blessmann M, Izbicki JR, and Grupp K
- Subjects
- Humans, Prognosis, Biomarkers, Tumor metabolism, Prolyl Hydroxylases, Colorectal Neoplasms pathology
- Abstract
Background: Prolyl hydroxylase 1 (PHD1) is a prognostic marker in several cancers., Aims and Scopes: This study was undertaken to elucidate the clinical relevance of PHD1 in colorectal cancer (CRC) prognosis., Materials and Methods: We compared PHD1 expression on a tissue microarray (TMA) containing samples from 1800 CRCs with corresponding clinicopathological tumor variables and patient survival., Results: While PHD1 staining was always high in benign colorectal epithelium, high PHD1 staining was detectable in only 71.8% of CRCs. Low PHD1 staining was associated with advanced tumor stage (p = 0.0101) and shortened overall survival in CRC patients (p = 0.0011). In a multivariable analysis including tumor stage, histological type and PHD1 staining revealed tumor stage and histological type (p < 0.0001 each), but also PHD1 staining (p = 0.0202) to be independent prognostic markers for CRC., Conclusions: In our cohort, loss of PHD1 expression independently identified a subset of CRC patients with poor overall survival and might, thus, be a promising prognostic marker. PHD1 targeting may even allow for specific therapeutic approaches for these patients., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
3. Are transgender people satisfied with their lives?
- Author
-
Grupp K, Blessmann M, König HH, and Hajek A
- Subjects
- Humans, Surveys and Questionnaires, Emotions, Personal Satisfaction, Transgender Persons psychology, Sex Reassignment Surgery
- Abstract
Background: Our goal was to examine the proportion of transgender people satisfied with their lives (i.e., cognitive evaluation of life as a whole) and the determinants of life satisfaction level among transgender individuals., Methods: Data were taken from the HH-TPCHIGV study. Included were 104 transgender people who had joined self-help groups to get and share information about the gender-affirming surgeries performed at the Division of Plastic, Reconstructive and Aesthetic Surgery at the University Medical Center Hamburg-Eppendorf. The established Satisfaction with Life Scale was used to quantify life satisfaction. Sociodemographic-, lifestyle-related and health-related determinants were included in multiple linear regressions. In regression analysis, life satisfaction served as outcome measure and in a robustness check ordered probit regressions were used., Results: Among transgender people, 12.9% can be classified as "extremely dissatisfied", 18.3% can be classified as "dissatisfied", 12.9% can be classified as "slightly dissatisfied", 7.5% as "neutral", 30.1% as "slightly satisfied", 17.2% as "satisfied" and 1.1% as "extremely satisfied". Higher levels of life satisfaction were associated with higher age (β = .15, p < .05), higher school education (β = 5.54, p < .001), and favorable self-rated health (β = 2.20, p < .001)., Conclusions: Nearly half of the transgender people were at least "satisfied" with their lives. Knowledge about the correlates of life satisfaction may assist in addressing unsatisfied individuals., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
4. Loneliness and Social Isolation among Transgender and Gender Diverse People.
- Author
-
Hajek A, König HH, Blessmann M, and Grupp K
- Abstract
Here, we report the prevalence of loneliness and social isolation and investigate the levels of loneliness and social isolation among transgender and gender diverse people using cross-sectional data from the HH-TPCHIGV study. Using the De Jong Gierveld tool, we assess loneliness, using the Bude and Lantermann tool, we assess perceived social isolation and using the Lubben Social Network Scale, we assess objective social isolation. The prevalence rate of loneliness was 83.3% (perceived social isolation: 77.7%; objective social isolation: 34.4%). Regressions revealed that favorable outcomes (i.e., lower loneliness levels, lower perceived social isolation, and lower objective social isolation) were consistently associated with higher school education. Beyond that, we identify an association between particularly poor health-related factors and higher loneliness and objective social isolation levels. We also report that unemployment was significantly associated with higher levels of perceived social isolation. In conclusion, we show high prevalence rates of loneliness and social isolation among transgender and gender diverse people. Additionally, important correlates (e.g., education, health-related factors, or unemployment) were identified. Such knowledge may provide help to address transgender and gender diverse people at risk for loneliness and social isolation.
- Published
- 2023
- Full Text
- View/download PDF
5. Prevalence and Determinants of Depressive and Anxiety Symptoms among Transgender People: Results of a Survey.
- Author
-
Hajek A, König HH, Buczak-Stec E, Blessmann M, and Grupp K
- Abstract
Objectives: The aim was to investigate the prevalence of probable depression and probable anxiety and to investigate the determinants of depressive symptoms and anxiety symptoms among transgender people., Methods: In this "Transgender Survey" (n = 104) we included transgender people who had joined self-help groups to obtain and share information about the gender-affirming surgeries performed at the Division of Plastic, Reconstructive and Aesthetic Surgery at the University Medical Center Hamburg-Eppendorf. Data collection took place between April and October 2022. To measure probable depression, the patient health questionnaire-9 was used. The generalized anxiety disorder-7 was used to quantify probable anxiety., Results: The prevalence of probable depression was 33.3% and it was 29.6% for probable anxiety. Multiple linear regressions showed that both more depressive symptoms and anxiety symptoms were significantly associated with younger age (β = -0.16, p < 0.01; β = -0.14, p < 0.01), being unemployed (e.g., full-time employed compared to unemployment: β = -3.05, p < 0.05; β = -2.69, p < 0.05), worse self-rated health (β = -3.31, p < 0.001; β = -1.88, p < 0.05), and having at least one chronic disease (β = 3.71, p < 0.01; β = 2.61, p < 0.05)., Conclusions: Remarkably high prevalence rates were identified among transgender people. Furthermore, risk factors of poor mental health (e.g., unemployment or younger age) were identified-which can help to address transgender people at risk for poor mental health.
- Published
- 2023
- Full Text
- View/download PDF
6. Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region.
- Author
-
Nguyen L, Blessmann M, Schneider SW, and Herberger K
- Subjects
- Humans, Middle Aged, Prospective Studies, Skin, Rejuvenation, Radio Waves, Neck
- Abstract
Background: Radiofrequency microneedling (RFMN) treatment is the latest generation of fractional skin rejuvenation methods., Objective: To evaluate the efficacy, safety, tolerability and patient satisfaction of RFMN treatment for skin rejuvenation of the lower face and neck area., Materials and Methods: A prospective, intraindividual, controlled study. Subjects were treated with a fractional insulated RFMN system with 1 to 3 sessions at intervals of 4 to 12 weeks. Follow-up visits were scheduled on Day 90 and 180 posttreatment. Outcome was assessed by volume analysis of standardized 3-dimensional imaging, and validated clinical scales were rated by the physician, a blinded investigator, and patients., Results: Thirty patients (mean age 55.5 years, Fitzpatrick skin type I-IV) were included. Mean submental volume difference was -4.72 cm3 (±10.07 cm3; range -26.65 cm3 to +16.01 cm3). Physician, blinded investigator, and subjects rated the clinical outcome as highly improved. Mean pain intensity was 5.61/10 on Numeric Rating Scale. Beside slight swelling and redness, no relevant downtime has been observed., Conclusion: Fractional RFMN treatment is a safe and effective technique for rejuvenation of the lower face, jawline, and neck region. Sufficient pain management should be provided. Data indicated low to no downtime and high patient satisfaction., (Copyright © 2022 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
7. Aberrant expression of Sec61α in esophageal cancers.
- Author
-
Bachmann K, Bockhorn M, Mann O, Gebauer F, Blessmann M, Izbicki JR, and Grupp K
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma pathology, Adult, Aged, Aged, 80 and over, Esophageal Neoplasms diagnosis, Esophageal Neoplasms pathology, Esophageal Squamous Cell Carcinoma diagnosis, Esophageal Squamous Cell Carcinoma pathology, Female, Humans, Immunohistochemistry, Male, Middle Aged, Predictive Value of Tests, Prognosis, Tissue Array Analysis, Adenocarcinoma metabolism, Esophageal Neoplasms metabolism, Esophageal Squamous Cell Carcinoma metabolism, SEC Translocation Channels metabolism
- Abstract
Introduction: The heterotrimeric Sec61α translocon complex is topological located in the membrane of the endoplasmic reticulum (ER) and allows protein transport and calcium across the membrane. Recently, aberrant expression of Sec proteins was linked to carcinogenesis and prognosis of patients., Materials and Methods: Here, we analysed the role of Sec61α in esophageal cancer, and we analysed Sec61α staining on a tissue microarray containing more than 600 esophageal cancer specimens by immunohistochemistry., Results: Sec61α staining was always strong in benign esophagus, but was only found in 5% of interpretable esophageal adenocarcinomas (EACs) and 14.5% of squamous cell carcinomas (ESCCs). Reduced Sec61α staining was not strongly linked to tumor phenotype in both subgroups of esophageal cancers and was unrelated to clinical outcome of patients (EACs: p = 0.8051 and ESCCs: p = 0.2751)., Conclusions: Thus, Sec61α measurement has not an additional prognostic benefit for the patients.
- Published
- 2019
- Full Text
- View/download PDF
8. Clinical outcome of patients undergoing abdominoplasty after massive weight loss.
- Author
-
Hunecke P, Toll M, Mann O, Izbicki JR, Blessmann M, and Grupp K
- Subjects
- Adult, Bariatric Surgery, Female, Humans, Male, Middle Aged, Obesity, Morbid surgery, Postoperative Complications epidemiology, Reoperation, Retrospective Studies, Risk Factors, Treatment Outcome, Abdominoplasty adverse effects, Abdominoplasty methods, Abdominoplasty statistics & numerical data, Weight Loss physiology
- Abstract
Background: Abdominoplasty is one of the most commonly performed surgical procedures to reshape the body contour in patients who have undergone massive weight loss., Objectives: This study was undertaken to assess the clinical outcome, complication rates, and risk factors for complications of patients undergoing abdominoplasty after massive weight loss., Setting: University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Method: Clinical outcome was retrospectively analyzed in 121 patients, who underwent abdominoplasty. The retrospective analysis included demographic data of patients, such as sex, age, body mass index (BMI), and pre-existing illnesses. Moreover, postoperative complications including seroma, hematoma, wound infection, and tissue necrosis were analyzed., Results: In our study cohort, the median age was 43.7 years, the median weight was 94.7 kg, and the median BMI was 32.3 kg/m
2 . The majority of included patients were women (70.3%). Death occurred in none of the patients. Among individuals, wound infection occurred in 3.3%, tissue necrosis in 1.7%, seroma in 7.4%, and hematoma in 3.3% of patients during the postoperative course. Reoperations were necessary in 2 patients (1.7%) due to postoperative bleeding and tissue necrosis of the navel. Tissue necrosis was significantly more often seen in a subset individual with type 2 diabetes (P = .006). Moreover, the rate of reoperations was significantly higher in patients with pre-existing cardiovascular illnesses compared with cardiovascular healthy patients (P = .036). Multivariate analysis analyzing risk factors for postoperative complications, including sex, age, BMI, diabetes, pulmonary disease, and cardiovascular disease, revealed strong independent relevance for type 2 diabetes (P = .024)., Conclusions: We found that abdominoplasty is a safe operative procedure. In addition, the risk for complications is significantly increased in the subgroup of diabetic patients and patients with cardiovascular diseases., (Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
9. Separating Response of Tumor and non-Tumor Cells to Drug In Vitro by Quantifying a Mutation.
- Author
-
Kleinpoppen M, Moebius C, Grupp K, Kluwe L, and Blessmann M
- Subjects
- Biomarkers, Tumor metabolism, Cell Line, Tumor, Cell Survival drug effects, Dose-Response Relationship, Drug, Feasibility Studies, Humans, Melanoma enzymology, Melanoma genetics, Melanoma pathology, Polymerase Chain Reaction, Proto-Oncogene Proteins B-raf metabolism, Skin Neoplasms enzymology, Skin Neoplasms genetics, Skin Neoplasms pathology, Antineoplastic Agents pharmacology, Biomarkers, Tumor antagonists & inhibitors, Biomarkers, Tumor genetics, DNA Mutational Analysis methods, Melanoma drug therapy, Mutation, Proto-Oncogene Proteins B-raf antagonists & inhibitors, Proto-Oncogene Proteins B-raf genetics, Skin Neoplasms drug therapy, Vemurafenib pharmacology
- Abstract
Background/aim: Conventional in vitro assays measure the effect of drugs on total cells, while separating the effect to those on tumor and non-tumor cells is important for assessing drug specificity. Our aim was to evaluate the feasibility of separating the efficacy of vemurafenib on tumor and non-tumor cells in a mixed culture., Materials and Methods: Melanoma A2058 cells and CCD18Co non-tumor cells were mixed and treated with vemurafenib. DNA was subjected to digital PCR to determine the ratio of the mutant 1799A to the wild-type 1799T alleles and viabilities of total cells were subsequently calculated as percentages of tumor and non-tumor cells., Results: The set-up proportion of tumor cells correlated well with the calculated one. The calculated viability of tumor cells decreased with increasing doses of vemurafenib while that of the non-tumor cells remained rather constant. Variability of digital PCR data was high., Conclusion: Using the BRAF mutation 1799T>A to separate the response of tumor and non-tumor cells to a drug, such as vemurafenib, is feasible, supporting a foundation for a genetic in vitro tool for testing drug efficacy and specificity., (Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
10. Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.
- Author
-
Melling N, Bachmann K, Hofmann B, El Gammal AT, Reeh M, Mann O, Moebius C, Blessmann M, Izbicki JR, and Grupp K
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Tumor biosynthesis, Carcinoma, Non-Small-Cell Lung pathology, Female, Humans, Immunohistochemistry, Lung Neoplasms pathology, Male, Middle Aged, Neoplasm Staging, Prevalence, Tissue Array Analysis, Carcinoma, Non-Small-Cell Lung metabolism, Lung Neoplasms metabolism, RNA-Binding Proteins biosynthesis
- Abstract
Introduction: Aberrant expression of RNA-binding motif protein 3 (RBM3) has been suggested as a prognostic biomarker in several malignancies., Materials and Methods: This study was performed to analyse the prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers (NSCLCs). Therefore, we took advantage of our tissue microarray (TMA) containing more than 600 NSCLC specimens., Results: While nuclear RBM3 staining was always high in normal lung tissue, high RBM3 staining was only seen in 77.1% of 467 interpretable non-metastatic NSCLCs. Reduced RBM3 staining was significantly associated with advanced pathological tumor stage (pT) in NSCLCs (p = 0.0031). Subset analysis revealed that the association between reduced RBM3 staining and advanced pT stage was largely driven by the histological subgroup of lung adenocarcinoma (LUACs) (p = 0.0036). In addition, reduced RBM3 expression predicted shortened survival in LUAC patients (p = 0.0225)., Conclusions: In summary, our study shows that loss of RBM3 expression predicts worse clinical outcome in LUAC patients.
- Published
- 2019
- Full Text
- View/download PDF
11. Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes.
- Author
-
Münscher A, Prochnow S, Gulati A, Sauter G, Lörincz B, Blessmann M, Hanken H, Böttcher A, and Clauditz TS
- Subjects
- Female, Humans, Male, Neoplasm Grading, Predictive Value of Tests, Prognosis, Retrospective Studies, Squamous Cell Carcinoma of Head and Neck mortality, Squamous Cell Carcinoma of Head and Neck pathology, Squamous Cell Carcinoma of Head and Neck therapy, Survival Rate, Tissue Array Analysis, Treatment Outcome, Biomarkers, Tumor metabolism, Squamous Cell Carcinoma of Head and Neck metabolism, Survivin metabolism
- Abstract
Objectives: Strong expression of survivin is associated with worse survival in many different tumours, and in cell culture, a correlation between radiation resistance and survivin expression can be seen. The potential of survivin expression as a prognostic/predictive marker or therapeutic target has not been examined in head and neck squamous cell carcinomas (HNSCC) yet., Material and Methods: Retrospective study of 452 tissue samples and clinical data from patients with squamous cell carcinomas of the larynx/hypopharynx (LSCC), oral cavity (OSCC) and oropharynx (OPSCC) treated in the University Medical Centre Hamburg-Eppendorf between 2002 and 2006. The expression patterns were detected by tissue microarray technique and correlated with clinical parameters (sex, age, tumour location, TNM 7th edition, grading, recurrence-free and overall survival)., Results: 222 OSCC, 126 OPSCC and 105 LSCC tumours of 118 females and 335 males with a mean follow-up of 41.3 months were examined. Survivin expression correlates with pN, cM, pT and overall survival., Conclusion and Clinical Relevance: The potential of survivin as a prognostic/predictive marker is very high. The findings have to be confirmed in a larger cohort of HNSCC esp. in those tumours treated primarily with radio/radiochemotherapy.
- Published
- 2019
- Full Text
- View/download PDF
12. Health-related quality of life and patient burden in patients with split-thickness skin graft donor site wounds.
- Author
-
Humrich M, Goepel L, Gutknecht M, Lohrberg D, Blessmann M, Bruning G, Diener H, Dissemond J, Hartmann B, and Augustin M
- Subjects
- Adult, Aged, Cross-Sectional Studies, Female, Germany, Humans, Male, Middle Aged, Surgical Wound Infection etiology, Chronic Disease psychology, Chronic Disease therapy, Quality of Life psychology, Skin Transplantation adverse effects, Skin Transplantation psychology, Surgical Wound Infection therapy, Transplant Donor Site physiopathology, Wound Healing physiology
- Abstract
Split-thickness skin grafting is a common procedure to treat different kinds of wounds. This systematic, multicentre, observational, cross-sectional study of adult patients with split-thickness skin graft (STSG) donor site wounds was conducted to evaluate quality of life (QoL) impairments caused by donor site wounds following split-thickness skin grafting. Therefore, 112 patients from 12 wound centres in Germany were examined based on patient and physician questionnaires as well as a physical examination of the donor site wound. Most indications for skin grafting were postsurgical treatment (n = 51; 42.5%) and chronic wounds (n = 47; 39.2%). European QoL visual analoque scale (EQ VAS) averaged 64.7 ± 23.3, European QoL 5 dimensions (EQ-5D) averaged 77.4 ± 30.0. Wound-QoL (range: 0-4) was rated 0.8 ± 0.8 post-surgery and 0.4 ± 0.6 at the time of survey (on average 21 weeks between the time points). Compared to averaged Wound-QoL scores of chronic wounds donor site-related QoL impairments in split-thickness skin-graft patients were less pronounced. There were significant differences in patient burden immediately after surgery compared to the time of the survey, with medium effect sizes. This supports the hypothesis that faster healing of the donor site wound leads to more favourable patient-reported outcomes., (© 2017 Medicalhelplines.com Inc and John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
13. EZH2 overexpression in head and neck cancer is related to lymph node metastasis.
- Author
-
Nienstedt JC, Schroeder C, Clauditz T, Simon R, Sauter G, Muenscher A, Blessmann M, Hanken H, and Pflug C
- Subjects
- Biomarkers, Tumor metabolism, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Female, Follow-Up Studies, Head and Neck Neoplasms mortality, Head and Neck Neoplasms pathology, Humans, Immunohistochemistry, Male, Prognosis, Tissue Array Analysis, Carcinoma, Squamous Cell metabolism, Enhancer of Zeste Homolog 2 Protein metabolism, Head and Neck Neoplasms metabolism, Lymphatic Metastasis
- Abstract
Background: Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of the polycomb repressive complex 2, plays an important role in tumor development and progression by interacting with histone and non-histone proteins. EZH2 represents a putative therapeutic target and has been suggested as a prognostic marker in several cancer types., Material and Methods: This study investigates the prognostic relevance of immunohistochemical EZH2 expression in head and neck squamous cell carcinoma. Tissue microarray sections with 667 cancers of oral cavity, oro- and hypopharynx and larynx were analyzed for EZH2 expression., Results: Nuclear EZH2 staining was recorded in 322 (81.8%) of 394 cases. Staining was weak in 33 (10.2%), moderate in 128 (39.6%), and strong in 103 (32.0%) cancers. The prevalence of EZH2 expression in tumors of the oral cavity and the orohypopharynx was higher as compared to cancers of the larynx (P = .0023). EZH2 expression was correlated to presence of lymph node metastasis (P = .0089) but was unrelated to histological grade, tumor stage, surgical margin, or distant metastasis. EZH2 expression had no impact on patient survival., Conclusion: The high prevalence of EZH2 expression in head and neck squamous cell carcinoma stresses its capability as a therapeutic target., (© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
14. High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome.
- Author
-
Nienstedt JC, Gröbe A, Clauditz T, Simon R, Muenscher A, Knecht R, Sauter G, Moebius C, Blessmann M, Heiland M, and Pflug C
- Subjects
- Carcinoma, Squamous Cell chemistry, Female, Head and Neck Neoplasms chemistry, Humans, Immunohistochemistry, Male, Prognosis, Squamous Cell Carcinoma of Head and Neck, Tubulin analysis, Carcinoma, Squamous Cell genetics, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms genetics, Tubulin genetics
- Abstract
Background: βIII-tubulin (TUBB3) is an isotype of microtubules, which are involved in crucial cellular roles including maintenance of cell shape, intracellular transport, and mitosis. Overexpression of TUBB3 was found to be associated with poor prognosis and resistance to tubulin-binding drugs and in several solid tumors including head and neck squamous cell carcinomas (HNSCC). Considering the potential high importance of a prognostic biomarker in these cancers, this study aimed to investigate the clinical relevance of immunohistochemical TUBB3 expression in HNSCC., Methods: Tissue microarray (TMA) sections containing samples from 667 cancers of oral cavity, oro- and hypopharynx, and larynx for which follow-up data were available were analyzed for TUBB3 expression by immunohistochemistry., Results: Over 90% of our analyzed cancers showed unequivocal cytoplasmic TUBB3 expression. Staining was considered weak in 69 (15.5%), moderate in 149 (33.5%), and strong in 188 (42.2%) of cancers. The frequent TUBB3 overexpression showed no significant correlation with pathological grading, tumor stage, nodal status, or surgical margin and had no impact on patient outcomes., Conclusion: Despite lacking prognostic utility in HNSCC, the remarkable high prevalence of TUBB3 expression in HNSCC emphasizes its putative relevance as a target for future drugs targeting TUBB3., (© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
15. CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.
- Author
-
Nienstedt JC, Gröbe A, Lebok P, Büscheck F, Clauditz T, Simon R, Heumann A, Sauter G, Moebius C, Münscher A, Knecht R, Blessmann M, Heiland M, and Pflug C
- Subjects
- Biomarkers, Tumor metabolism, Female, Head and Neck Neoplasms pathology, Humans, Immunohistochemistry, Male, Neoplasm Grading, Neoplasm Staging, Prognosis, Tissue Array Analysis, Head and Neck Neoplasms metabolism, Tetraspanin 24 metabolism
- Abstract
Objectives: CD151 is a plasma membrane protein belonging to the tetraspanin family. CD151 represents a putative therapeutic target and has been suggested as a prognostic marker in several cancer types. The present study aims to investigate the prognostic relevance of immunohistochemical CD151 expression in head and neck squamous cell carcinoma (HNSCC)., Materials and Methods: Tissue microarray (TMA) sections containing samples from 667 cancers of oral cavity, oro- and hypopharynx and larynx, for which follow-up data were available, were analyzed for CD151 expression by immunohistochemistry., Results: Membranous CD151 immunostaining was recorded in 269 (60.3 %) of 446 analyzable cases. Staining was considered weak in 129 (28.9 %), moderate in 98 (22.0 %), and strong in 42 (9.4 %) of cancers. CD151 expression was unrelated to histological grade, tumor stage, nodal status, or surgical margin. There was a tendency towards a somewhat lower prevalence of CD151 expression in tumors of the oral cavity (52.9 % positive) as compared to cancers of the oro-hypopharynx (62.1 %) and larynx (63.3 %; p = 0.0100). CD151 expression had no impact on patient survival., Clinical Relevance: In summary, immunohistochemical analysis of CD151 lacks prognostic utility in HNSCC. The high prevalence of CD151 expression in HNSCC emphasizes its putative relevance as a therapeutic target for further development of anti-CD151 drugs.
- Published
- 2017
- Full Text
- View/download PDF
16. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
- Author
-
Precht C, Blessmann M, Kluwe L, Scheld T, Schön G, Henningsen A, Pflug C, Smeets R, Heiland M, and Gröbe A
- Subjects
- Adult, Aged, Aged, 80 and over, Alleles, Biomarkers, Tumor analysis, Carcinoma, Squamous Cell mortality, Female, Genotype, Germany epidemiology, Humans, Immunohistochemistry, Male, Middle Aged, Mouth Neoplasms mortality, Neoplasm Staging, Polymerase Chain Reaction, Prognosis, Survival Analysis, Carcinoma, Squamous Cell genetics, Dinucleotide Repeats genetics, ErbB Receptors genetics, Introns genetics, Mouth Neoplasms genetics, Polymorphism, Genetic
- Abstract
Epidermal growth factor receptor (EGFR) expression is altered in several malignancies, including oral squamous cell carcinoma. A CA-repeat polymorphism in intron-1 (CA-SSR-1) of the EGFR gene is reported to influence EGFR expression and is associated with features of various solid tumors and outcomes of cancer patients. In the present study we evaluated the influence of length and zygosity of CA-SSR-1 on the survival of patients with oral squamous cell carcinoma. The length and zygosity of CA-SSR-1 was obtained through microsatellite analysis in 91 patients with oral cancer, who were treated in the Department of Oral and Maxillofacial Surgery of the University Medical Centre Hamburg Eppendorf, Germany, during the years 1998-2008. Follow up was conducted until 2016. Outcome measures were age, gender, tumor stage, occurrence of metastases, and date of recurrence or death. Statistical analysis was conducted using the chi-square test and the log-rank test. Neither length nor zygosity of the CA-SSR-1 in patients with oral squamous cell carcinoma was significantly correlated with sex, age, tumor size, tumor localization, lymph node involvement, metastasis status, disease-free survival, or overall survival. Length and zygosity of the CA-SSR-1 polymorphism in EGFR is not able to serve as a prognostic biomarker in White European patients with oral squamous cell carcinoma., (© 2017 Eur J Oral Sci.)
- Published
- 2017
- Full Text
- View/download PDF
17. Technical and surgical aspects of the sphenopalatine ganglion (SPG) microstimulator insertion procedure.
- Author
-
Assaf AT, Hillerup S, Rostgaard J, Puche M, Blessmann M, Kohlmeier C, Pohlenz P, Klatt JC, Heiland M, Caparso A, and Papay F
- Subjects
- Cluster Headache diagnostic imaging, Cone-Beam Computed Tomography, Electric Stimulation Therapy adverse effects, Electric Stimulation Therapy instrumentation, Equipment Design, Ganglia, Parasympathetic diagnostic imaging, Humans, Pain Management instrumentation, Pain Measurement, Pterygopalatine Fossa diagnostic imaging, Radiography, Interventional, Tomography, X-Ray Computed, Cluster Headache physiopathology, Cluster Headache therapy, Electric Stimulation Therapy methods, Ganglia, Parasympathetic physiopathology, Pain Management methods
- Abstract
Cluster headache (CH) is a debilitating, severe form of headache. A novel non-systemic therapy has been developed that produces therapeutic electrical stimulation to the sphenopalatine ganglion (SPG). A transoral surgical technique for inserting the Pulsante SPG Microstimulator into the pterygopalatine fossa (PPF) is presented herein. Technical aspects include detailed descriptions of the preoperative planning using computed tomography or cone beam computed tomography scans for presurgical digital microstimulator insertion into the patient-specific anatomy and intraoperative verification of microstimulator placement. Surgical aspects include techniques to insert the microstimulator into the proper midface location atraumatically. During the Pathway CH-1 and Pathway R-1 studies, 99 CH patients received an SPG microstimulator. Ninety-six had a microstimulator placed within the PPF during their initial procedure. Perioperative surgical sequelae included sensory disturbances, pain, and swelling. Follow-up procedures included placement of a second microstimulator on the opposite side (n=2), adjustment of the microstimulator lead location (n=13), re-placement after initial unsuccessful placement (n=1), and removal (n=5). This SPG microstimulator insertion procedure has sequelae comparable to other oral cavity procedures including tooth extractions, sinus surgery, and dental implant placement. Twenty-five of 29 subjects (86%) completing a self-assessment questionnaire indicated that the surgical effects were tolerable and 90% would make the same decision again., (Copyright © 2015 International Association of Oral and Maxillofacial Surgeons. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
18. Attachment, Viability and Adipodifferentiation of Pre-adipose Cells on Silk Scaffolds with and Without Co-expressed FGF-2 and VEGF.
- Author
-
Hanken H, Göhler F, Smeets R, Heiland M, Gröbe A, Friedrich RE, Busch P, Blessmann M, Kluwe L, and Hartjen P
- Subjects
- Biocompatible Materials chemistry, Biocompatible Materials therapeutic use, Cell Adhesion drug effects, Cell Differentiation drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Cells, Cultured, Fibroblast Growth Factor 2 genetics, Gene Expression Regulation, Developmental drug effects, Humans, Regenerative Medicine, Silk chemistry, Tissue Engineering, Tissue Scaffolds adverse effects, Vascular Endothelial Growth Factor A genetics, Adipose Tissue drug effects, Fibroblast Growth Factor 2 biosynthesis, Silk therapeutic use, Vascular Endothelial Growth Factor A biosynthesis
- Abstract
Background/aim: For application of stem cells and progenitor cells in regenerative medicine, scaffolds for carrying the cells play a key role. One promising biomaterial for scaffold generation is silk because of its mechanical strength, good cytocompatibility and low immunogenicity. Furthermore, bioengineering of silk proteins enable co-expression of various growth, differentiation and angiogenic factors on silk fibers, which may promote cell growth, differentiation and angiogenesis. This study aimed to test cytocompatibility and growth/differentiation of pre-adipose cells on scaffolds with and without expressed growth factors fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF)., Materials and Methods: Disk-form scaffolds of 15×3 mm (diameter × thickness) were manufactured in two different densities using silk with and without expressed growth factors FGF-2 or VEGF. Pre-adipose cells were prepared from fatty tissues of patients undergoing operation. Cells (1.6×10(6)) were seeded onto each of the silk-scaffold disks, that were placed into wells of 12-well culturing plates. Adipose-differentiation was induced using differentiation medium containing DMEM/F-12, insulin, pantothenate, biotin, triiodothyronine (T3), transferrin, dexamethasone, isobuthylmethylxanthine and rosiglitazone. Cells on the scaffolds were visualized using a confocal microscope. Viability and adiponectin were measured on days 0, 7 and 14. Expression of adipose-differentiation markers was assessed by means of real-time polymerase chain reaction (RT-PCR)., Results: Pre-adipose cells attached well onto the silk fibers. The highest initial viability was measured on the low-density scaffolds with expressed VEGF. Adipose-differentiation was evident in visible oil droplets and significantly increased adiponectin protein levels were seen in ELISA. Furthermore, increased expression of adipose-differentiation genes were measured in RT-PCR. Adipose-differentiation was more profound in cells on high-density scaffolds. In concordance, viability of cells on high-density scaffolds did not increase, while that of cells on low-density scaffolds doubled over the 14-day experimental period. Slightly enhanced adipose-differentiation was observed in cells on scaffolds with expressed FGF-2 or VEGF., Conclusion: Silk scaffolds exhibit excellent cytocompatibility for human pre-adipose cells and have application potential in tissue engineering and regenerative medicine. VEGF and FGF-2 expressed on silk fibers could have a potential positive effect on pre-adipose cells, while the effect of VEGF should be further addressed in vivo., (Copyright © 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)
- Published
- 2016
19. Local full-thickness skin graft of the donor arm--a novel technique for the reduction of donor site morbidity in radial forearm free flap.
- Author
-
Riecke B, Assaf AT, Heiland M, Al-Dam A, Gröbe A, Blessmann M, and Wikner J
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Radial Artery, Suture Techniques, Wound Healing, Forearm surgery, Free Tissue Flaps blood supply, Head and Neck Neoplasms surgery, Plastic Surgery Procedures methods, Skin Transplantation methods
- Abstract
A novel technique to reduce donor site morbidity after radial forearm free flap (RFFF) harvest, using a local full-thickness skin graft (FTSG), is described. Thirty consecutive patients undergoing RFFF for head and neck reconstruction were enrolled in a prospective study. Donor site defect closure was performed with spindle-shaped FTSGs excised from the wavelike skin incision made for the vascular pedicle. Both the removal site of the FTSG on the volar forearm and the covered RFFF donor site healed uneventfully in 29 cases, with no impairment of function related to the skin graft. No skin graft failure and no exposure, tenting, or adherence of the flexor tendons occurred. All patients expressed satisfaction with postoperative pain, the functional outcome, and cosmetic appearance. Primary donor site defect closure could be achieved in all cases with the use of a local FTSG. This graft can be gained at the access incision for the vascular pedicle, avoids expansion of the incision for a local flap technique, and does not prolong wound healing, and thus reduces both donor site and graft site morbidity of the RFFF. This technique leads to an inconspicuous aesthetic result with no apparent relevant functional deficits and avoids the need for a second donor site., (Copyright © 2015 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
20. Impact of malpositioning on panoramic radiography in implant dentistry.
- Author
-
Riecke B, Friedrich RE, Schulze D, Loos C, Blessmann M, Heiland M, and Wikner J
- Subjects
- Equipment Design, Humans, Radiography, Panoramic standards, Reproducibility of Results, Dental Implants, Radiographic Magnification standards
- Abstract
Objectives: The widely used panoramic radiography as a special kind of tomography underlies intrinsic procedural restrictions such as poor definition, inconsistent magnification, geometric distortion and spatial depositioning of objects situated outside the focal trough. This results in a non-anatomic display of the radiographed anatomic structures. Individual mandibular angle and width of the jaws, adjustment of the focal trough, jaw incongruence as well as patient positioning increase the inconsistency in display of the radiographed objects. This study precisely evaluated the quantitative impact of object malpositioning on the display in panoramic radiography., Materials and Methods: A special dental implant model was highly accurate three dimensionally malpositioned and panoramic radiographs were taken. Automated image analysis was performed to exclude subjective assessment error., Results: Precise and retraceable object deposition of up to 5 mm or 5° resulted in relevant deposition of objects and significant changes in object size and inter-object distances in the panoramic image. Unidirectional malpositioning lead to multiple errors in display., Conclusions: The extent of malpositioning-related display errors additionally to the known physicotechnical insufficiencies of the panoramic radiography demonstrates its limitations in precisely interpreting spatial relationships., Clinical Relevance: Measurements within the panoramic radiography must not claim reliability. For a single object securely positioned in the focal trough and perpendicular to the central X-ray beam, measurements may be trustworthy on clinical scale. Once sterical relationships to other structures are evaluated, reliability must be questioned.
- Published
- 2015
- Full Text
- View/download PDF
21. Value of intra- and post-operative cone beam computed tomography (CBCT) for positioning control of a sphenopalatine ganglion neurostimulator in patients with chronic cluster headache.
- Author
-
Assaf AT, Klatt JC, Blessmann M, Kohlmeier C, Friedrich RE, Pohlenz P, May A, Heiland M, and Jürgens TP
- Subjects
- Adult, Aged, Equipment Design, Female, Foreign-Body Migration diagnostic imaging, Ganglia, Parasympathetic physiology, Humans, Image Processing, Computer-Assisted methods, Male, Maxillary Sinus diagnostic imaging, Middle Aged, Pterygopalatine Fossa diagnostic imaging, Reoperation, Retrospective Studies, Young Adult, Cluster Headache therapy, Cone-Beam Computed Tomography methods, Electric Stimulation Therapy instrumentation, Electrodes, Implanted adverse effects, Imaging, Three-Dimensional methods, Intraoperative Care, Postoperative Care, Pterygopalatine Fossa innervation
- Abstract
Introduction: The objective of this study was to determine whether postoperative control of the neurostimulator placement within the pterygopalatine fossa (PPF) by means of 3-dimensional (3D) cone beam computed tomography (CBCT) was of therapeutic relevance compared to intraoperative CBCT imaging alone., Material and Methods: Immediately after implantation of the sphenopalatine ganglion (SPG) neurostimulator, intraoperative CBCT datasets were generated in order to visualize the position of the probe within the PPF. Postoperatively, all patients received a CBCT for comparison with intraoperatively acquired radiographs., Results: Twenty-four patients with cluster headache (CH) received an SPG neurostimulator. In 4 patients, postoperative CBCT images detected misplacement not found in intraoperative CBCT. In 3 cases, electrode tips were misplaced into the maxillary sinus and in 1 case into the apex of the PPF superior to the suspected location of the SPG. Immediate revision with successful repositioning within 3 days was done in 2 patients and a deferred reimplantation in 1 patient within 6 months. One patient declined revision., Conclusion: We were able to demonstrate the clinical value of postoperative dental CBCT imaging with a wide region of interest (ROI) due to a superior image quality compared with that achieved with intraoperative medical CBCT. Although intraoperative 3D CBCT imaging of electrode placement is helpful in the acute surgical setting, resolution is, at present, too low to safely exclude misplacement, especially in the maxillary sinus. High-resolution postoperative dental CBCT allows rapid detection and revision of electrode misplacement, thereby avoiding readmission and recurrent tissue trauma., (Copyright © 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
22. Numb chin syndrome: a rare and often overlooked symptom.
- Author
-
Assaf AT, Jürgens TP, Benecke AW, Riecke B, Blessmann M, Zrnc TA, Much CC, Heiland M, and Friedrich RE
- Subjects
- Adult, Aged, Bisphosphonate-Associated Osteonecrosis of the Jaw diagnosis, Bone Substitutes adverse effects, Carcinoma secondary, Carcinoma, Adenoid Cystic diagnosis, Carcinoma, Small Cell secondary, Cranial Nerve Diseases diagnosis, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Lymphoma, B-Cell diagnosis, Male, Mandibular Diseases diagnosis, Mandibular Fractures diagnosis, Mandibular Neoplasms diagnosis, Mandibular Neoplasms secondary, Mandibular Nerve physiopathology, Middle Aged, Multiple Sclerosis diagnosis, Neoplasm Invasiveness, Nerve Compression Syndromes diagnosis, Chin innervation, Hypesthesia diagnosis
- Abstract
Numb chin syndrome (NCS) describes a sensory neuropathy characterized by numbness in the distribution of the terminal branch of the mandibular division of the trigeminal nerve. Benign as well as malignant diseases are known to cause NCS. This is often misdiagnosed, and in some cases the symptom may lead to a late detection of malignancy. Reports of 10 cases in which NCS was the presenting and isolated symptom, caused by extracranial malignancies, drugs, or dental/surgical interventions, are presented. This article outlines the symptoms and the diagnostic approaches taken, provides a short review of the etiology and pathogenesis, and proposes diagnostic criteria and treatment of NCS. Both medical practitioners and dentists need to be aware of the relationship between malignancies and paresthesia of the chin or complete loss of sensation in partial segments of the jaw. In addition, dentists should be aware of the diagnostic limitations of an orthopantomogram to detect underlying diseases beyond localized dental disorders.
- Published
- 2014
- Full Text
- View/download PDF
23. Outcome of microvascular free flaps in a high-volume training centre.
- Author
-
Al-Dam A, Zrnc TA, Hanken H, Riecke B, Eichhorn W, Nourwali I, Smeets R, Blessmann M, Heiland M, and Gröbe A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Clinical Competence, Critical Care, Dental Implants, Female, Follow-Up Studies, General Surgery education, Graft Survival, Head and Neck Neoplasms surgery, Humans, Internship and Residency, Length of Stay, Male, Middle Aged, Operative Time, Patient Care Team, Postoperative Complications, Radiotherapy, Adjuvant, Reoperation, Retrospective Studies, Tissue and Organ Harvesting methods, Treatment Outcome, Young Adult, Free Tissue Flaps transplantation, Plastic Surgery Procedures methods
- Abstract
Purpose: Microvascular free tissue transfer allows major ablative defects following oncologic surgical and traumatic reasons to be reliably reconstructed in the head and neck region. A retrospective analysis of the microvascular flap procedures which were performed within one year in a high volume training centre was performed., Patients and Methods: The microvascular free flap procedures of the year 2011 were reviewed and followed up until the 31st December 2012. The type and indication of the reconstructive procedure, operation time, operating team, experience and level of training of the surgeons involved, postoperative IMC (intermediate care unit) and/or ICU (intensive care unit) time, inpatient time, flap revisions, further postoperative complications, preoperative and postoperative radiation of the patients, the placement of dental implants were studied., Results: From 1st of January 2011 to 31st of December, 2011, the data of 101 patients with 103 microvascular free flap procedures were analysed of which 72% (84 flaps) were harvested by residents. The patients ranged in age from 14 to 89 years (mean age 59 years, 71 males and 40 females). The mean operation time was 591 min with the longest operation times for scapular flaps (744 min) and the shortest operation times for ALT flaps (455 min). Mean inpatient time was 34.2 days with a minimal time for the fibular flaps of 27.2 days and a maximum of 45.7 days for the latissimus dorsi flaps. 24 flaps (23.3%) in total had to be revised with bleeding being the main cause of immediate revisions (41.7% of all revisions). 5 flaps (4.85% of all flaps) were lost despite a revision procedure meaning a successful revision rate in 79.2% of all revisions., Conclusion: Microvascular reconstruction procedures are safe and should be considered as standard procedures for reconstruction of large defects especially in high volume training centres. Intensive flap monitoring and early revisions maximize the flap outcome., (Copyright © 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
24. Radiography-based score indicative for the pathogenicity of bacteria in odontogenic infections.
- Author
-
Cachovan G, Blessmann M, Schön G, Rother U, Heiland M, Stürenburg E, Platzer U, and Sobottka I
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Bacteroidaceae Infections diagnostic imaging, Clindamycin therapeutic use, Double-Blind Method, Female, Fluoroquinolones therapeutic use, Fusobacterium Infections diagnostic imaging, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Moxifloxacin, Periapical Abscess microbiology, Periodontal Abscess diagnostic imaging, Prospective Studies, Radiography, Staphylococcal Infections diagnostic imaging, Streptococcal Infections diagnostic imaging, Tooth Diseases diagnostic imaging, Virulence, Young Adult, Abscess diagnostic imaging, Bacteria pathogenicity, Periodontal Abscess microbiology, Tooth Diseases microbiology
- Abstract
Objective: To develop a new radiography-based score to assess the potential of bacteria to cause odontogenic infections derived from the occurrence of bacteria at small or large radiographical lesions., Materials and Methods: The patients analyzed were a sub-population from a large randomized clinical trial comparing moxifloxacin and clindamycin in the treatment of inflammatory infiltrates and odontogenic abscesses. Routine radiographs were used to analyze the area of the periapical radiolucent lesions. Lesions were stratified by their radiographically measured area as large (>9 mm(2)) or small (≤9 mm(2)). A risk ratio was calculated for each species from the frequency of their occurrence in large vs in small lesions., Results: Fifty-one patients, 19 with abscesses and 32 with infiltrates, were evaluated. Overall, the radiographical lesion areas ranged from 0.4-46.2 mm(2) (median = 9 mm(2)). An increased risk (risk ratio >1) to occur at large abscess lesions was observed for Prevotella (P.) oralis, P. buccae, P. oris, P. intermedia, Fusobacterium nucleatum and Streptococcus (Strep.) anginosus group. An increased risk to occur at large infiltrate lesions was found for Strep. salivarius, Strep. parasanguis, Strep. anginosus group, Capnocytophaga spp., Neisseria (N.) sicca, Neisseria spp., Staphylococcus (Staph.) aureus, P. intermedia, P. buccae, Prevotella spp. and P. melaninogenica., Conclusions: The radiography-based score suggests that certain Prevotella spp., F. nucleatum and Strep. anginosus groups play a crucial role in the pathogenesis of odontogenic abscesses, and that various streptococci, Neisseria spp., Capnocytophaga spp., Staph. aureus and Prevotella spp. are involved in the pathogenesis of odontogenic infiltrates.
- Published
- 2014
- Full Text
- View/download PDF
25. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
- Author
-
Clauditz TS, von Rheinbaben K, Lebok P, Minner S, Tachezy M, Borgmann K, Knecht R, Sauter G, Wilczak W, Blessmann M, and Münscher A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Cell Membrane metabolism, Cell Membrane pathology, Female, Humans, Immunohistochemistry methods, Male, Middle Aged, Prognosis, Squamous Cell Carcinoma of Head and Neck, Young Adult, Antigens, CD metabolism, Biomarkers, Tumor metabolism, Carcinoma, Squamous Cell metabolism, Cell Adhesion Molecules, Neuronal metabolism, Fetal Proteins metabolism, Head and Neck Neoplasms metabolism
- Abstract
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is expressed in a number of malignancies (e.g. prostate, breast, squamous cell carcinoma of the esophagus, lung and head and neck tumors). Based on studies in which ALCAM showed prognostic relevance in several carcinomas, it has been discussed as a potential therapeutic target. We evaluate its expression in head and neck squamous cell carcinomas (HNSCCs). A tissue microarray was constructed from more than 400 HNSCCs. Slides were analyzed by immunohistochemistry for ALCAM. Membranous and cytoplasmic ALCAM positivity were rated separately. The tumors were combined into (a) cases with membranous staining and (b) cases with cytoplasmic staining, independently from membranous/cytoplasmic co-expression. We found staining in 70.3% of interpretable HNSCCs. Pure membranous staining was found in 12.4% of tumors, with cytoplasmic positivity in 40.1% of cases, and membranous/cytoplasmic co-expression in 17.9%. No significant association between ALCAM positivity and clinical parameters was found. No significant association between ALCAM expression and survival data was observed for all tumors. The frequent expression of ALCAM (70.3%) in head and neck squamous cell carcinomas does not support an important role for HNSCC biology. The increased levels of ALCAM suggest the existence of a therapeutic window for potential anti-ALCAM therapies., (Copyright © 2014 Elsevier GmbH. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
26. Fractal dimension of time-resolved autofluorescence discriminates tumour from healthy tissues in the oral cavity.
- Author
-
Klatt J, Gerich CE, Gröbe A, Opitz J, Schreiber J, Hanken H, Salomon G, Heiland M, Kluwe L, and Blessmann M
- Subjects
- Area Under Curve, Carcinoma, Squamous Cell diagnosis, Early Detection of Cancer, Fluorescence, Forecasting, Humans, Lasers, Sensitivity and Specificity, Spectrometry, Fluorescence instrumentation, Time Factors, Fractals, Mouth Mucosa anatomy & histology, Mouth Neoplasms diagnosis, Optical Imaging methods
- Abstract
Early detection and complete resection of oral carcinomas is of crucial importance for patient survival. This could be significantly improved by developing a non-invasive, sensitive and real-time detection technique. Time-resolved autofluorescence measurement is state-of-the-art technology originally developed for non-destructive inspection of material. In this study, we measured time-resolved autofluorescence in tumours and healthy tissues of the oral cavity ex vivo and calculated the corresponding fractal dimension which was significantly higher in tumours than in healthy tissues (1.8 vs. 1.6, P < 0.001, unpaired t-test) with non-overlapping 95% confidential intervals 1.88-1.84 and 1.57-1.69, respectively. Very high specificity (86%) could be reached at 100% sensitivity. The area under the curve was 99%, further suggesting the superior prediction potential of fractal dimension based on time-resolved autofluorescence spectra., (Copyright © 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
27. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
- Author
-
Laban S, Atanackovic D, Luetkens T, Knecht R, Busch CJ, Freytag M, Spagnoli G, Ritter G, Hoffmann TK, Knuth A, Sauter G, Wilczak W, Blessmann M, Borgmann K, Muenscher A, and Clauditz TS
- Subjects
- Adult, Aged, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell radiotherapy, Cytoplasm immunology, Female, Head and Neck Neoplasms drug therapy, Head and Neck Neoplasms radiotherapy, Humans, Male, Middle Aged, Nuclear Proteins immunology, Prognosis, Risk, Squamous Cell Carcinoma of Head and Neck, Antigens, Neoplasm biosynthesis, Antigens, Neoplasm immunology, Biomarkers, Tumor biosynthesis, Carcinoma, Squamous Cell mortality, Head and Neck Neoplasms mortality, Melanoma-Specific Antigens biosynthesis, Membrane Proteins biosynthesis, Neoplasm Proteins immunology
- Abstract
The prognosis of head and neck squamous cell carcinoma (HNSCC) patients remains poor. The identification of high-risk subgroups is needed for the development of custom-tailored therapies. The expression of cancer-testis antigens (CTAs) has been linked to a worse prognosis in other cancer types; however, their prognostic value in HNSCC is unclear because only few patients have been examined and data on CTA protein expression are sparse. A tissue microarray consisting of tumor samples from 453 HNSCC patients was evaluated for the expression of CTA proteins using immunohistochemistry. Frequency of expression and the subcellular expression pattern (nuclear, cytoplasmic, or both) was recorded. Protein expression of melanoma antigen (MAGE)-A family CTA, MAGE-C family CTA and NY-ESO-1 was found in approximately 30, 7 and 4% of tumors, respectively. The subcellular expression pattern in particular had a marked impact on the patients' prognosis. Median overall survival (OS) of patients with (i) simultaneous cytoplasmic and nuclear expression compared to (ii) either cytoplasmic or nuclear expression and (iii) negative patients was 23.0 versus 109.0 versus 102.5 months, for pan-MAGE (p < 0.0001), 46.6 versus 50.0 versus 109.0 for MAGE-A3/A4 (p = 0.0074) and 13.3 versus 50.0 versus 100.2 months for NY-ESO-1 (p = 0.0019). By multivariate analysis, these factors were confirmed as independent markers for poor survival. HNSCC patients showing protein expression of MAGE-A family members or NY-ESO-1 represent a subgroup with an extraordinarily poor survival. The development of immunotherapeutic strategies targeting these CTA may, therefore, be a promising approach to improve the outcome of HNSCC patients., (© 2014 UICC.)
- Published
- 2014
- Full Text
- View/download PDF
28. Postoperative bleeding risk for cutaneous surgery in the head and neck region with continued phenprocoumon therapy.
- Author
-
Eichhorn W, Barsukov E, Al-Dam A, Gröbe A, Smeets R, Eichhorn M, Heiland M, Kluwe L, and Blessmann M
- Subjects
- Aftercare, Age Factors, Aged, Aged, 80 and over, Ambulatory Surgical Procedures methods, Bandages, Blood Transfusion, Female, Follow-Up Studies, Hematoma etiology, Hemostasis, Surgical methods, Humans, International Normalized Ratio, Male, Mohs Surgery methods, Nose surgery, Plastic Surgery Procedures methods, Risk Assessment, Surgical Flaps surgery, Anticoagulants therapeutic use, Dermatologic Surgical Procedures methods, Head and Neck Neoplasms surgery, Phenprocoumon therapeutic use, Postoperative Hemorrhage etiology
- Abstract
In a total of 171 surgical procedures for lesions in the head and neck region in patients in whom phenprocoumon therapy was not stopped, 16 (9%) postoperative bleeding events were observed over a follow-up period of two weeks. Local measures were sufficient in all cases except one severe case where blood transfusion was needed and anticoagulant treatment was stopped for 7 days. The bleeding risk was significantly higher for the surgical procedures of the nose than those in other areas (21% versus 6%, P = 0.014), but was not influenced by the international normalized ratio (INR) of blood coagulation, size, site and type of the lesion, surgical procedure, and sex and age of the patients. The bleeding rate in patients not on any anticoagulation therapy was significantly lower (6/211 = 3%). Across both groups, just over 80% of the bleeding episodes were within the first two days (55% on the same day and 32% on the next day) of the surgery. No bleeding was recorded after 5 days. Our data suggest that cutaneous surgery in the head and neck region can be safely performed with continued phenprocoumon therapy in most cases in an INR range of 1.3-3.4, but rarely severe bleeding does occur and can be managed with a close-contact follow-up and with 24-h on call services during the first two days postoperatively., (Copyright © 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
29. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
- Author
-
Hanken H, Gaudin R, Gröbe A, Fraederich M, Eichhorn W, Smeets R, Simon R, Sauter G, Grupp K, Izbicki JR, Sehner S, Heiland M, and Blessmann M
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell secondary, Female, Follow-Up Studies, Gene Expression Regulation, Neoplastic genetics, Head and Neck Neoplasms chemistry, Head and Neck Neoplasms genetics, Head and Neck Neoplasms pathology, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Lymph Nodes pathology, Male, Middle Aged, Mouth Floor chemistry, Mouth Floor pathology, Mouth Neoplasms genetics, Mouth Neoplasms pathology, Neoplasm Grading, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Pharyngeal Neoplasms chemistry, Pharyngeal Neoplasms genetics, Pharyngeal Neoplasms pathology, Phenotype, Receptor, ErbB-2 genetics, Survival Rate, Tissue Array Analysis methods, Carcinoma, Squamous Cell chemistry, Gene Amplification genetics, Mouth Neoplasms chemistry, Receptor, ErbB-2 analysis
- Abstract
Purpose: Her2 (ErbB2) transforms cells when overexpressed and is an important therapeutic target in breast cancer. Contrary to breast cancer, studies on Her2 overexpression and gene amplification in squamous cell carcinomas of the head and neck region described largely different results. This study was undertaken to learn more on the prevalence and clinical significance of HER2 amplification and overexpression in squamous cell carcinomas of the head and neck., Materials and Methods: Her2 expression and gene amplification was analyzed by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) on two tissue microarrays composed of 427 squamous cell carcinomas of the head and neck region and 222 oral squamous cell carcinomas. Results were compared with clinicopathological features., Results: Her2 expression and gene amplification was rarely detectable in squamous cell carcinomas of the head and neck region and unrelated to tumor phenotype or survival of the patients with oral squamous carcinoma., Discussion: Our results demonstrate that Her2 protein and gene amplification was only detectable in a small subset of squamous cell carcinomas of the head and neck region as well as oral squamous cell carcinomas. However, it can be speculated that those few patients with Her2 overexpressing and gene amplificated tumors may possibly benefit from an anti-Her2 therapy., (© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
30. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
- Author
-
Gröbe A, Eichhorn W, Fraederich M, Kluwe L, Vashist Y, Wikner J, Smeets R, Simon R, Sauter G, Heiland M, and Blessmann M
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell secondary, Disease-Free Survival, ErbB Receptors genetics, Female, Gene Amplification genetics, Head and Neck Neoplasms chemistry, Head and Neck Neoplasms pathology, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence methods, Ki-67 Antigen analysis, Lymph Nodes pathology, Lymphatic Metastasis pathology, Male, Middle Aged, Mouth Neoplasms pathology, Neoplasm Grading, Neoplasm Staging, Prognosis, Survival Rate, Young Adult, Carcinoma, Squamous Cell chemistry, ErbB Receptors analysis, Mouth Neoplasms chemistry
- Abstract
Objectives: To study immunohistochemical expression of the epithelial growth factor receptor (EGFR) in oral carcinomas and the head and neck region to examine possible associations with various features of the tumors and survival of the patients., Materials and Methods: Sections were made from two tissue arrays composed of 206 oral squamous cell carcinomas and 427 squamous cell carcinomas of the head and neck region, respectively, and examined for EGFR expression and Ki-67 labeling index by means of immunohistochemistry, and for EGFR gene amplification by means of fluorescence in situ hybridization. Correlation between resulting parameters and with clinical features was evaluated using chi-square test and Kaplan-Meyer analysis., Results: A statistically significant association was observed for strong EGFR immunohistochemical (IHC) expression with advanced lymph node involvement (P = 0.02). EGFR immunohistochemical expression did not significantly correlate with patient disease specific (DS) or overall survival (OS). EGFR gene amplification was not correlated with any of the tumor features nor to survival of the patients (DS and OS)., Discussion: Epithelial growth factor receptor IHC expression and gene amplification might be suitable to predict locoregional control in oral squamous cell carcinoma patients but an inappropriate predictor for patients survival., (© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
31. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
- Author
-
Gröbe A, Blessmann M, Hanken H, Friedrich RE, Schön G, Wikner J, Effenberger KE, Kluwe L, Heiland M, Pantel K, and Riethdorf S
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell mortality, Female, Humans, Male, Middle Aged, Mouth Neoplasms mortality, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Recurrence, Tumor Burden, Bone Marrow pathology, Bone Marrow Neoplasms secondary, Carcinoma, Squamous Cell pathology, Mouth Neoplasms pathology, Neoplastic Cells, Circulating pathology
- Abstract
Purpose: Current staging methods for squamous cell carcinomas (SCC) of the oral cavity (OSCC) need to be improved to predict the risk of individual patients. Because hematogenous tumor cell dissemination is a key event in tumor progression, we assessed the prognostic significance of disseminated tumor cells (DTC) in bone marrow and circulating tumor cells (CTC) in peripheral blood from patients with OSCC., Experimental Design: From 110 patients with OSCC, tumors were surgically resected (R0) without neoadjuvant therapy. The CellSearch system was used to enumerate CTCs. Bone marrow was aspirated from the iliac crest, and mononuclear cells (MNC) were enriched by Ficoll density gradient centrifugation. To detect DTCs, MNCs were immunostained with the pan-keratin antibody A45-B/B3. Results were correlated with clinicopathologic parameters and clinical outcome such as recurrence and death during follow-up time (mean 916 days)., Results: Ten of 80 patients (12.5%) harbored CTCs in peripheral blood, whereas in 18 of 90 patients (20.0%) DTCs in bone marrow could be detected. Surprisingly, in only 2 patients (1.8%) CTCs and DTCs were detected simultaneously. Significant correlations could be found for CTCs and tumor size (P = 0.04), nodal status and DTCs (P = 0.02), and distant metastasis with CTCs (P = 0.004) and DTCs (P = 0.005). Univariate and multivariate analyses revealed that CTCs and DTCs were significant and independent predictors of recurrence-free survival (P < 0.001)., Conclusions: Both DTCs and CTCs are independent prognostic markers in patients with OSCC, predicting relapse with higher sensitivity at various disease stages than routine staging procedures. Bone marrow might be an interesting target organ for future therapeutic interventions., (©2013 AACR.)
- Published
- 2014
- Full Text
- View/download PDF
32. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
- Author
-
Atac A, Riecke B, Assaf AT, Gröbe A, Friedrich RE, Heiland M, Izbicki JR, Kluwe L, and Blessmann M
- Subjects
- Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell pathology, Case-Control Studies, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Mouth Neoplasms genetics, Mouth Neoplasms pathology, Neoplasm Recurrence, Local genetics, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Prognosis, Survival Rate, Carcinoma, Squamous Cell mortality, Cyclin D1 genetics, Mouth Neoplasms mortality, Neoplasm Recurrence, Local mortality, Polymorphism, Single Nucleotide genetics
- Abstract
Background/aim: Cyclin D1 gene (CCND1) has a G to A polymorphism at the splice donor site of exon 4, position 870. The A allele codes for a truncated variant, cyclin D1b, which may have higher transforming activity. Data regarding the predictive and prognostic value of the CCND1 G870A polymorphism in tumors are controversial. We aimed to examine this polymorphism in patients with oral carcinoma., Materials and Methods: Genotyping of CCND1 G870A was determined by means of direct sequencing in 83 patients with oral carcinomas and in 102 healthy controls. Association with clinical outcomes was evaluated statistically., Results: We failed to find any significant association of CCND1 G870A with risk of oral carcinomas in this German population, with clinical and pathological features of the tumours or with overall survival of the patients., Conclusion: Our results suggest that CCND1 G870A has no, or only very limited, predictive and prognostic value for oral carcinoma.
- Published
- 2014
33. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
- Author
-
Hanken H, Gröbe A, Cachovan G, Smeets R, Simon R, Sauter G, Heiland M, and Blessmann M
- Subjects
- Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell pathology, Cyclin D1 genetics, Head and Neck Neoplasms genetics, Head and Neck Neoplasms pathology, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Ki-67 Antigen metabolism, Lymphatic Metastasis, Survival Analysis, Carcinoma, Squamous Cell metabolism, Cyclin D1 metabolism, Head and Neck Neoplasms metabolism
- Abstract
Objectives: Gene products, which show a significant association to cell proliferation and cell cycle control, are of high scientific interest, because genes as well as gene products could be possible targets for a specific therapeutic approach and eventually be prognostic markers., Materials and Methods: Cyclin D1 expression and amplification as well as the Ki-67 expression status were examined in a two tissue microarray analysis for head and neck squamous cell carcinoma (HNSCC) including 546 patients. A tumour site-specific analysis and a survival analysis of 222 oral squamous cell carcinoma (OSCC) patients were performed. Cyclin D1 amplification status was examined with fluorescence in situ hybridisation analysis, while cyclin D1 expression and Ki-67 expression status were examined with IHC., Results: Amplification of the CCND1 gene and immunohistochemical expression of cyclin D1 and Ki-67 were examined in 546 tumours of the head and neck region in two tissue microarrays. CCND1 amplification was significantly more frequent in pharyngeal carcinomas (63%) than in laryngeal (37%) and oral (25%) carcinomas. Among the 222 cases of OSCCs, both CCND1 amplification and cyclin D1 expression were significantly associated with overall survival of the patients (p = 0.0127 and p = 0.0004, respectively). Ki-67 expression was significantly associated with cyclin D1 expression and with amplification of the CCND1 gene (p = 0.0002 and p = 0.0015, respectively) but not with patient overall survival., Conclusion: Our results suggest the prognostic value of CCND1 amplification and cyclin D1 expression for patients with OSCC and highlight the genetic differences in HNSCC of different subanatomic localisation., Clinical Relevance: Cyclin D1 expression and CCND1 amplification seem to have a prognostic value for OSCC. Further studies of HNSCC should always consider subanatomic genetic differences.
- Published
- 2014
- Full Text
- View/download PDF
34. P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region.
- Author
-
Gröbe A, Hanken H, Al-Dam A, Cachovan G, Smeets R, Krohn A, Clauditz T, Grob T, Simon R, Sauter G, Kluwe L, Heiland M, and Blessmann M
- Subjects
- Alphapapillomavirus isolation & purification, Base Sequence, Carcinoma, Squamous Cell pathology, DNA Primers, Female, Head and Neck Neoplasms pathology, Head and Neck Neoplasms virology, Humans, Immunohistochemistry, Male, Mouth Neoplasms pathology, Mouth Neoplasms virology, Polymerase Chain Reaction, Prognosis, Carcinoma, Squamous Cell metabolism, Head and Neck Neoplasms metabolism, Mouth Neoplasms metabolism, Tumor Suppressor Protein p53 metabolism
- Abstract
Objectives: The present study aims to investigate the relevance of immunohistochemical p53 expression in carcinomas of the oral cavity and of the head and neck region. Long-term clinical and histopathological follow-up findings as well as HPV status are correlated with the results of this examination., Materials and Methods: Sections made from two tissue arrays composed of 222 oral squamous cell carcinomas and 427 squamous cell carcinomas of the head and neck region, respectively, were examined for p53 expression and Ki-67 index by means of immunohistochemistry. Correlation of long-term clinical findings of the patients and pathological features of tumours with laboratory results were examined statistically., Results: No significant correlation was found between the p53 immunohistochemical expression in the 207 oral carcinomas and features of the tumours and patient outcomes. There was no significant association between the Ki-67 labelling index and the p53 expression., Discussion: Our failure in detecting any association of the p53 immunohistochemical expression regardless of HPV status with clinical features of these tumours suggests it lacks a prognostic value for squamous cell carcinomas of the oral cavity., Clinical Relevance: The prognostic value of p53 immunostaining in oral squamous carcinoma is not clarified yet. In the present study, there is no impact on any prognostical item nor even a correlation with cell proliferation (Ki-67) regardless of HPV status.
- Published
- 2014
- Full Text
- View/download PDF
35. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC).
- Author
-
Blessmann M, Al-Dam A, Hanken H, Assaf AT, Riecke B, Klatt J, Simon R, Sauter G, Heiland M, Kluwe L, and Gröbe A
- Subjects
- Biomarkers, Tumor analysis, Cyclin D1 genetics, DNA Probes, DNA, Neoplasm genetics, Female, Humans, In Situ Hybridization, Fluorescence, Laryngeal Neoplasms genetics, Male, Neoplasm Grading, Neoplasm Staging, Oligonucleotide Array Sequence Analysis, Pharyngeal Neoplasms genetics, Tissue Array Analysis, Adaptor Proteins, Signal Transducing genetics, Carcinoma, Squamous Cell genetics, Cell Adhesion Molecules genetics, Chromosomes, Human, Pair 11 genetics, Gene Amplification genetics, Mouth Neoplasms genetics
- Abstract
Introduction: Analyzing chromosomal amplifications delivers valuable information for identification of oncogenes. For carcinomas of the oral cavity only few genes have been identified in amplified regions. The aim of this study was to search genes in amplified regions as possible biomarkers and targets for novel therapies., Material and Methods: DNA from 10 carcinomas of the floor of the oral cavity was examined using a 500K Array GeneChip (Affymetrix 6.0) to detect chromosomal losses, gains or amplifications. Suspicious alterations were validated on tissue microarrays using fluorescence in situ hybridization (FISH) with respective probes., Results: FISH-validation on tissue arrays confirmed PPFIA1 amplifications as one of the most frequent events (32.6%). High (10-20 signals) and low (<10 signals) amplification of PPFIA1 was found in 10.9% (5/46) and 21.7% (10/46) tumours, respectively. Fine mapping with overlapping FISH probes showed co-amplification of PPFIA1 and the Cyclin D1 gene which are approximately 600 kb apart from each other, likely in the same amplicon., Discussion: PPFIA1 was frequently co-amplified with the Cyclin D1 gene in oral carcinomas and could present a biomarker as well as a novel target for specific gene therapy. Further studies are necessary to investigate the role of PPFIA1 in development and pathogenesis of oral carcinomas., (Copyright © 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
36. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
- Author
-
Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, Clauditz T, Grob T, Simon R, Sauter G, Heiland M, and Blessmann M
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell virology, Cell Nucleus pathology, Disease-Free Survival, Female, Human papillomavirus 16 isolation & purification, Human papillomavirus 18 isolation & purification, Humans, Immunohistochemistry, Laryngeal Neoplasms pathology, Laryngeal Neoplasms virology, Lymph Nodes pathology, Male, Middle Aged, Mouth Neoplasms virology, Neoplasm Grading, Neoplasm Staging, Oropharyngeal Neoplasms pathology, Oropharyngeal Neoplasms virology, Prognosis, Survival Rate, Young Adult, Alphapapillomavirus isolation & purification, Carcinoma, Squamous Cell pathology, Cyclin-Dependent Kinase Inhibitor p16 analysis, Mouth Neoplasms pathology, Papillomavirus Infections virology
- Abstract
Objectives: Functional inactivation of p16 is an early and frequent event in the carcinogenesis of tumours of the head and neck region. However, the prognostic relevance of p16 protein expression for these tumours has been controversial. This study aims to examine immunohistochemical expression of p16 and HP virus in a large number of oral carcinomas, and possible correlation with clinical features of the tumours and survival of the patients., Methods: Two tissue microarrays composed of 222 oral carcinomas and 427 squamous cell carcinomas of the head and neck region were used for this study. Sections were stained immunohistochemically (anti-p16), and PCR analysis (HPV status) was carried out. Correlation of p16 expression/HPV status with features of tumours and with survival of the patients was analysed by means of Chi-squared test and using Kaplan-Meier analysis, respectively., Results: p16 expression was found immunohistochemically in 74% of tumours, but was not significantly correlated with features of the tumours, but recurrence-free survival of the patients (P = 0.009) if located predominantly nuclear. On the other hand neither intensity of p16 expression (P = 0.41) nor HPV status (P = 0.82) had any effect on these two aspects., Conclusion: Immunohistochemical expression of p16 alone provides a limited tool for diagnosis and prognosis of carcinomas of the head and neck region. Immunohistochemical analysis of p16 depending on its intracellular location might serve as a surrogate marker for HPV infection., (© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
37. Mandibular cortical shape index in non-standardised panoramic radiographs for identifying patients with osteoporosis as defined by the German Osteology Organization.
- Author
-
Al-Dam A, Blake F, Atac A, Amling M, Blessmann M, Assaf A, Hanken H, Smeets R, and Heiland M
- Subjects
- Absorptiometry, Photon methods, Accidental Falls, Adult, Aged, Aged, 80 and over, Bone Density physiology, Bone Diseases, Metabolic diagnosis, Female, Femur diagnostic imaging, Fractures, Bone classification, Hip Fractures classification, Humans, Lumbar Vertebrae diagnostic imaging, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Reproducibility of Results, Risk Factors, Sensitivity and Specificity, Smoking, Young Adult, Mandible diagnostic imaging, Osteoporosis diagnosis, Radiography, Panoramic statistics & numerical data
- Abstract
The aim of this prospective controlled study was to determine the validity of the mandibular cortical shape index (CI) on panoramic radiographs in distinguishing patients with osteoporosis as defined by the German Osteology Organization (Dachverbands der Deutschsprachigen Osteologischen Fachgesellschaften, DVO). The study group contained 50 patients (33 female, 17 male, mean age: 74.9 years), who had a high risk of osteoporosis. 50 young patients (33 female, 17 male, mean age: 37.9 years) with no anamnestic evidence of osteoporosis served as control. Three blinded observers evaluated panoramic views of the study and the control group in a mixed manner regarding the mandibular cortical shape index. The study group underwent bone mineral density measurement using dual energy X-ray absorptiometry and received a diagnosis according to the Organization's guidelines (normal, osteopenia, osteoporosis). The CI showed a high sensitivity of 72.2% and a high specificity of 93.9% with a highly significant predictive value (Chi-square = 22.96, p < 0.001), while the observer's agreement was moderate (kappa = 0.47). We concluded that patients with a cortical shape index of the category assessed as "severe" on non-standardised panoramic radiographs have a higher risk of suffering systemic osteoporosis. The CI in panoramic radiographs is a good screening tool, which could be implemented in the routine assessment of panoramic radiographs in elder patients., (Crown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
38. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
- Author
-
Assaf AT, Smeets R, Riecke B, Weise E, Gröbe A, Blessmann M, Steiner T, Wikner J, Friedrich RE, Heiland M, Hoelzle F, and Gerhards F
- Subjects
- Bisphosphonate-Associated Osteonecrosis of the Jaw complications, Bone Density Conservation Agents administration & dosage, Bone Density Conservation Agents therapeutic use, Bone Neoplasms secondary, Diphosphonates administration & dosage, Diphosphonates therapeutic use, Female, Humans, Incidence, Male, Middle Aged, Zoledronic Acid, Bisphosphonate-Associated Osteonecrosis of the Jaw epidemiology, Bone Density Conservation Agents adverse effects, Bone Neoplasms drug therapy, Diphosphonates adverse effects, Imidazoles adverse effects
- Abstract
Background: Since its first description by Marx in 2003, the etiology of bisphosphonate-related osteonecrosis of the jaw (BRONJ) is the subject of numerous scientific discussions for oral and maxillofacial surgeons. Many retrospective studies on its etiology and pathogenesis have been carried out to explain pathological mechanisms; most of them just take a close look at the issue of dosage and application. Recently, attempts have been made, to identify co-factors which might promote the development of BRONJ., Patients and Methods: The present study is based on data of 169 patients with osseous metastatic malignancies. All patients received intravenous bisphosphonate therapy. On the basis of medical history, malignancy, and primary treatment, the modality of bisphosphonate therapy, and existing comorbidities and medication were analyzed. The role of immunosuppressive drugs, influence of underlying diseases, and general factors such as age and gender were examined. The predictability of necrotic involvement, influenced by the underlying malignancy and its specific therapy, e.g. radiation and cytostatic therapy were analyzed and statistically evaluated., Results: A total of 8.9% (n=15) of patients developed BRONJ. The average time between diagnosis of malignancy and BRONJ was 80 months. Nine patients suffered from breast cancer, five had prostate cancer and one renal cancer. Separation into stage and histological subtype did not show any significant correlation, nor did age or gender, to the occurrence of BRONJ. However statistical analysis did show a significant correlation concerning monocytostatic (p=0.0215) and triple-cytostatic therapy (p=0.0137). The majority of patients with BRONJ (60%) received a bisphosphonate therapy including zoledronate. Single application with one bisphosphonate was administered in 28 cases; 44 patients had a medical history of different use of bisphosphonate. Concomitant medication did not suggest possible correlation, nor did accompanying diseases, arterial hypertension (33.33%) or arterial microcirculatory disturbances (20%)., Conclusion: The evaluation of our results is pioneering. The influence of cytostatics and combined therapy of cytotoxic drugs on the pathogenesis of BRONJ is demonstrated here statistically. We confirmed a drug- and dose-dependent occurrence of BRONJ. Further prospective studies should be performed to elucidate the role of tissue perfusion and oxygen saturation, and the influence of immunosuppressive drugs in relation to the occurrence of BRONJ, as well as on wound healing of initial lesions.
- Published
- 2013
39. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation.
- Author
-
Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M, Eichhorn W, Clauditz TS, Gröbe A, Kolk A, and Rana M
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell pathology, Female, Humans, Male, Middle Aged, Mouth Mucosa pathology, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Early Detection of Cancer instrumentation, Mouth Neoplasms diagnosis, Optical Imaging instrumentation, Precancerous Conditions diagnosis
- Abstract
Objective: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precursors. The use of VELscope® using an autofluorescence as a diagnostic tool might be useful in early detection of oral malignant lesions., Materials and Methods: 120 patients with suspicious oral premalignant lesions were examined with two examination methods. They were randomly divided into two groups. Group 1 was examined conventional with white-light and group 2 was examined additionally to the white-light-examination with an autofluorescence visualization device, VELscope®. Biopsies were obtained from all suspicious areas identified in both examination groups (n = 52). The diagnostic strategies were compared regarding sensitivity and specificity., Results: Based upon the result, use of the VELscope® leads to a higher sensitivity (22.0%), but regarding specificity the additional use of the VELscope® is inferior (8.4%)., Conclusion: The VELscope device is a simple, non-invasive test of the oral mucosa, which can help the experienced clinician to find oral precursor malignant lesions.
- Published
- 2013
- Full Text
- View/download PDF
40. The innovative application of a novel bone adhesive for facial fracture osteosynthesis-in vitro and in vivo results.
- Author
-
Smeets R, Endres K, Stockbrink G, Hanken H, Hermanns-Sachweh B, Marx R, Heiland M, Blessmann M, Wolff KD, and Kolk A
- Subjects
- Adhesiveness, Animals, Biomechanical Phenomena, Bone Cements, Dogs, Facial Bones pathology, Polymethyl Methacrylate, Rabbits, Skull drug effects, Skull growth & development, Tensile Strength, Facial Bones injuries, Fracture Fixation, Internal methods, Skull Fractures drug therapy, Tissue Adhesives therapeutic use
- Abstract
This study evaluates a novel adhesive fixation technique to affix cortical bone fragments to osteosynthesis plates using common PMMA cement. This technique utilizes a new amphiphilic bone bonding agent adhering with both hydrophilic bone and hydrophobic PMMA cement. After in vitro biomechanical testing of the bonding strength with explanted bovine and rabbit calvarian bone samples, osteosynthesis plates with screw holes of 1.3 and 1.5 mm were placed on the cranial bone of New Zealand white rabbits and the bond strength of these plates was determined through tension tests. In vitro bond strengths of 19.8-26.5 MPa were obtained. Control samples, prepared without a bone bonding agent, exhibited bone bonding strengths <0.2 MPa. In vivo respective bond strengths at the cranium of the white rabbits were 2.5-4.1 MPa 2 weeks post surgery and 1.9-2.5 MPa 12 weeks after implantation. This new innovative fixation method can be envisioned for cases in which conventional fixation techniques of screws and plates are insufficient or not possible due to the bone or trauma conditions. The observed bonding strengths support implementing this technique in nonload bearing regions, such as the central midface or frontal sinus, facilitating immobilization until bone reunion is complete., (Copyright © 2012 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
41. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
- Author
-
Tribius S, Sommer J, Prosch C, Bajrovic A, Muenscher A, Blessmann M, Kruell A, Petersen C, Todorovic M, and Tennstedt P
- Subjects
- Adult, Aged, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell surgery, Chemoradiotherapy, Adjuvant, Chemotherapy, Adjuvant, Combined Modality Therapy, Dose Fractionation, Radiation, Female, Humans, Male, Middle Aged, Neoplasm Staging, Otorhinolaryngologic Neoplasms drug therapy, Otorhinolaryngologic Neoplasms pathology, Otorhinolaryngologic Neoplasms surgery, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Retrospective Studies, Survival Analysis, Carcinoma, Squamous Cell radiotherapy, Otorhinolaryngologic Neoplasms radiotherapy, Parotid Gland radiation effects, Radiation Injuries etiology, Radiotherapy, Intensity-Modulated, Xerostomia etiology
- Abstract
Purpose: Xerostomia is a debilitating side effect of radiotherapy in patients with head and neck cancer. We undertook a prospective study of the effect on xerostomia and outcomes of sparing one or both parotid glands during radiotherapy for patients with squamous cell carcinoma of the head and neck., Methods and Materials: Patients with locally advanced squamous cell carcinoma of the head and neck received definitive (70 Gy in 2 Gy fractions) or adjuvant (60-66 Gy in 2 Gy fractions) curative-intent radiotherapy using helical tomotherapy with concurrent chemotherapy if appropriate. Group A received < 26 Gy to the left and right parotids and group B received < 26 Gy to either parotid., Results: The study included 126 patients; 114 (55 in group A and 59 in group B) had follow-up data. There were no statistically significant differences between groups in disease stage. Xerostomia was significantly reduced in group A vs. group B (p = 0.0381). Patients in group A also had significantly less dysphagia. Relapse-free and overall survival were not compromised in group A: 2-year relapse-free survival was 86% vs. 72% in group B (p = 0.361); 2-year overall survival was 88% and 76%, respectively (p = 0.251)., Conclusion: This analysis suggests that reducing radiotherapy doses to both parotid glands to < 26 Gy can reduce xerostomia and dysphagia significantly without compromising survival. Sparing both parotids while maintaining target volume coverage and clinical outcome should be the treatment goal and reporting radiotherapy doses delivered to the individual parotids should be standard practice.
- Published
- 2013
- Full Text
- View/download PDF
42. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
- Author
-
Clauditz TS, Wang CJ, Gontarewicz A, Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow C, Knecht R, Münscher A, and Wilczak W
- Subjects
- Adult, Aged, Biomarkers, Tumor analysis, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell secondary, Cohort Studies, Disease-Free Survival, Female, Follow-Up Studies, Gene Expression Regulation, Neoplastic genetics, Head and Neck Neoplasms genetics, Humans, Immunohistochemistry, Insulin-Like Growth Factor Binding Protein 3 genetics, Laryngeal Neoplasms pathology, Lymphatic Metastasis pathology, Male, Middle Aged, Mouth Neoplasms pathology, Neoplasm Grading, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Oropharyngeal Neoplasms pathology, Prognosis, Protein Array Analysis, RNA, Messenger analysis, Retrospective Studies, Survival Rate, Carcinoma, Squamous Cell pathology, Head and Neck Neoplasms pathology, Insulin-Like Growth Factor Binding Protein 3 analysis
- Abstract
Background: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) was found overexpressed in various cancer types suggesting its possible role in carcinogenesis. Analysis of IMP3 expression in head and neck squamous cell carcinomas (HNSCC) is rare so that we evaluated it using tissue microarray method., Method: Immunohistochemical analysis of IMP3 was performed on samples from over 400 patients. The expression was measured semiquantitative, subsequently divided into four categories (negative, weak, medium, or strong) and correlated with several available clinicopathologic parameters., Results: For HNSCC, positive IMP3 expression was observed in patients with all tumor stages (pT1-4) and nodal stages (pN0-3), showing also significant statistical correlation (P=0.023 and P=0.0013, respectively). No further correlations were found. Separate analysis according to tumor localization (oral cavity, oropharyngeal, and laryngeal) showed a significant correlation of positive IMP3 expression and overall survival (P=0.038) only in patients with tumors of the oral cavity. Multivariate analysis showed IMP3 as an independent predictive marker for oral squamous cell carcinomas (OSCC)., Conclusion: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression might be used as an independent prognostic factor in the subgroup of OSCC., (© 2012 John Wiley & Sons A/S.)
- Published
- 2013
- Full Text
- View/download PDF
43. Current trends and future perspectives of bone substitute materials - from space holders to innovative biomaterials.
- Author
-
Kolk A, Handschel J, Drescher W, Rothamel D, Kloss F, Blessmann M, Heiland M, Wolff KD, and Smeets R
- Subjects
- Biocompatible Materials chemistry, Biopolymers chemistry, Bone Matrix chemistry, Bone Substitutes chemistry, Calcium Compounds chemistry, Ceramics chemistry, Forecasting, Humans, Tissue Scaffolds chemistry, Transplantation, Homologous, Biocompatible Materials therapeutic use, Bone Substitutes therapeutic use
- Abstract
An autologous bone graft is still the ideal material for the repair of craniofacial defects, but its availability is limited and harvesting can be associated with complications. Bone replacement materials as an alternative have a long history of success. With increasing technological advances the spectrum of grafting materials has broadened to allografts, xenografts, and synthetic materials, providing material specific advantages. A large number of bone-graft substitutes are available including allograft bone preparations such as demineralized bone matrix and calcium-based materials. More and more replacement materials consist of one or more components: an osteoconductive matrix, which supports the ingrowth of new bone; and osteoinductive proteins, which sustain mitogenesis of undifferentiated cells; and osteogenic cells (osteoblasts or osteoblast precursors), which are capable of forming bone in the proper environment. All substitutes can either replace autologous bone or expand an existing amount of autologous bone graft. Because an understanding of the properties of each material enables individual treatment concepts this review presents an overview of the principles of bone replacement, the types of graft materials available, and considers future perspectives. Bone substitutes are undergoing a change from a simple replacement material to an individually created composite biomaterial with osteoinductive properties to enable enhanced defect bridging., (Copyright © 2012 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
44. Bleeding incidence after oral surgery with continued oral anticoagulation.
- Author
-
Eichhorn W, Burkert J, Vorwig O, Blessmann M, Cachovan G, Zeuch J, Eichhorn M, and Heiland M
- Subjects
- Administration, Oral, Adult, Aged, Aged, 80 and over, Female, Hemostasis, Surgical, Humans, Incidence, International Normalized Ratio, Male, Middle Aged, Occlusal Splints, Osteotomy, Pain, Postoperative epidemiology, Retrospective Studies, Surgical Flaps, Tooth Extraction, Anticoagulants administration & dosage, Oral Surgical Procedures, Postoperative Hemorrhage epidemiology
- Abstract
Objectives: The aim of this retrospective study was to assess the incidence of postoperative hemorrhage in patients treated with coumarins without interruption of the anticoagulant treatment undergoing oral surgical procedures, mostly osteotomies for tooth removal, when compared with patients who had never been anticoagulated., Material and Methods: Six hundred thirty-seven patients underwent 934 oral surgical procedures on an outpatient basis. The INR was measured preoperatively being 2.44 in the mean SD 0.61. Local hemostasis was carried out routinely (80%) with collagen fleece, local flap, and acrylic splint., Results: Of these 637 patients, 47 presented with a postoperative hemorrhage (7.4%), 15 of these 47 cases had to be treated in hospital (2.4%). All patients showed up finally with a good wound healing, no administration of blood was necessary, and local measures revealed to be sufficient in all cases except for two patients, where the preoperative anticoagulant treatment had to be changed for 6 days. The bleeding incidence in 285 patients with comparable oral surgical procedures, who had never been anticoagulated, was 0.7%., Conclusions: The results suggest that oral surgical procedures can be performed safely without alteration of the oral anticoagulant treatment. CINICAL RELEVANCE: Local hemostasis with collagen fleece, local flap, and acrylic splint seems to be sufficient to prevent postoperative bleeding.
- Published
- 2012
- Full Text
- View/download PDF
45. An odontogenic keratocystic tumor in the buccal space: an unusual site of origin and a review of the literature.
- Author
-
Gröbe A, Hanken H, Blessmann M, Zustin J, Heiland M, and Al-Dam A
- Subjects
- Humans, Male, Middle Aged, Mouth Mucosa surgery, Odontogenic Cysts pathology, Odontogenic Cysts surgery, Radiography, Treatment Outcome, Mouth Mucosa pathology, Odontogenic Cysts diagnostic imaging
- Abstract
Aim: Keratocystic odontogenic tumors (KCOTs) arise from remnants of epithelial structures associated with the development of teeth and occur predominantly intraosseously. In rare occasions they can appear extraosseously in the gingiva as peripheral counterparts; only 15 cases have been reported to date. Evenmore rare are cases of KCOTs of the buccal soft tissues. The aim of this report is to present a rare case of KCOT affecting the buccal soft tissue as an original site and a review of the literature regarding diagnostic and therapeutic options.
- Published
- 2012
46. CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.
- Author
-
Gros SJ, Graeff H, Drenckhan A, Kurschat N, Blessmann M, Rawnaq T, and Izbicki JR
- Subjects
- Animals, Mice, Neoplasm Metastasis, Chemokine CXCL12 physiology, Chemotaxis physiology, Esophageal Neoplasms pathology, Receptors, CXCR4 physiology
- Abstract
Background/aim: The chemokine receptor CXCR4 and its ligand (stromal cell-derived factor-1alpha; SDF-1α) play an important role in tumor cell chemotaxis and metastatic homing of esophageal carcinoma. Several methods are available to examine tumor cell migration in vitro. However, in vivo chemotaxis is subject to complex tumor-host interactions. The aim of this study was to establish an in vivo model of chemotaxis for esophageal carcinoma that allows the examination of tumor cell migration and metastatic homing in the complex microenvironment., Materials and Methods: CXCR4 expression of OE19 adenocarcinoma cells was determined by immunostaining in an orthotopic esophageal model. SDF-1α-mediated migration of cells was examined in vitro. An in vivo model of chemotaxis and metastasis was established by subcutaneous injection of OE19 cells into NMRI/nu mice and by daily stimulation with SDF-1α., Results: CXCR4 is expressed in the primary tumor and in the metastatic tissue. CXCR4-positive OE19 cells are susceptible to SDF-1α-mediated migration. The novel in vivo model leads to developement of metastases in liver, lung, peritoneum and retroperitoneum after stimulation with SDF-1α but not with PBS, and revealed an SDF-1α dose-dependent migratory effect., Conclusion: As metastasis is still the leading cause of tumor-related death, it is essential to investigate the complex tumor-host interactions involved in metastatic homing. We established an in vivo model of chemotaxis and metastasis for esophageal carcinoma, which allows investigation and inhibition of CXCR4/SDF-1α-mediated cell survival and proliferation, chemotaxis and homing, adhesion, and tumor angiogenesis.
- Published
- 2012
47. Microvascular free flaps in head and neck surgery: complications and outcome of 1000 flaps.
- Author
-
Pohlenz P, Klatt J, Schön G, Blessmann M, Li L, and Schmelzle R
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Bone Transplantation, Child, Child, Preschool, Female, Follow-Up Studies, Graft Survival, Hematoma etiology, Humans, Male, Middle Aged, Muscle, Skeletal transplantation, Necrosis, Postoperative Hemorrhage etiology, Reoperation, Retrospective Studies, Skin Transplantation, Surgical Wound Dehiscence etiology, Thrombosis etiology, Transplant Donor Site pathology, Treatment Outcome, Young Adult, Free Tissue Flaps blood supply, Head and Neck Neoplasms surgery, Postoperative Complications, Plastic Surgery Procedures methods
- Abstract
This study analyzed the surgical outcome and complications of 1000 microvascular free flaps performed at the authors' institution in Germany, between 1987 and 2010. 972 patients underwent reconstruction with 1000 flaps: 28% latissimus dorsi flaps, 27% radial forearm flaps, 20% iliac crest flaps, 12% fibula flaps, 6% jejunal flaps, 2% anterolateral thigh flaps, and 5% other flaps. 130 failures (7.6%) were encountered, including 58 complete flap failures (44.6%) and 72 partial free-flap failures (55.4%). This study confirms that free flaps are extremely reliable in achieving successful reconstruction of the head and neck, but it is essential that complications be recognized and addressed early in their course to prevent or minimize devastating consequences. Owing to the large number of possible errors in flap transplantation, microsurgeons should always check everything for themselves. The on-duty doctors and nursing staff should not be trusted blindly. Venous thrombosis and cervical haematoma are the most common complications at the recipient site and are mainly responsible for flap failure, while complications occurring at the donor site may result from dehiscence and graft necrosis. When a compromised flap is identified, surgical re-exploration should not be deferred., (Copyright © 2012 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
48. L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.
- Author
-
Rawnaq T, Quaas A, Zander H, Gros SJ, Reichelt U, Blessmann M, Wilzcak W, Schachner M, Sauter G, Izbicki JR, and Kaifi JT
- Subjects
- Humans, Tissue Array Analysis, Biomarkers, Tumor metabolism, Nervous System Neoplasms metabolism, Neural Cell Adhesion Molecule L1 metabolism
- Abstract
Background: L1 cell adhesion molecule (CD171) has been detected in different malignant tumors and is associated with unfavorable outcome. It thus represents a target for tumor diagnosis and therapy. In this study, we assessed L1 expression in more than 8000 normal human tissues and different types of tumors, both malignant and non-malignant, and neural and non-neural., Materials and Methods: Tissue micro-arrays, including a multi-tumor-array of 128 different tumor types, up to 50 samples of each type (approximately 5500 different samples), arrays with approximately 3000 different prostate and 600 mesenchymal tumor samples, and a normal human tissue-array were analyzed by immunohistochemistry with a monoclonal antibody using immunoperoxidase staining., Results: L1 expression was detected in tumors of neural and neural crest origin and other types of non-neural tumors, but not in those of epithelial origin. In normal human tissues, L1 was detected in skin basal cells and small blood vessels, most notably in the mature placenta and peripheral nerves., Conclusion: This first comprehensive study of the importance of L1 expression in human demonstrates strong L1 overexpression in tumors of neuroectodermal and neural crest origin and an expression in only very few normal human tissues. L1 thus is a potentially important therapeutic target, particularly with respect to malignant melanoma, gastrointestinal stromal tumor, neuroblastoma, and certain subtypes of non-neural tumors., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
49. Extensive sublingual epidermoid cyst--diagnosis by immunohistological analysis and proof by podoplanin.
- Author
-
Assaf AT, Heiland M, Blessmann M, Friedrich RE, Zustin J, and Al-Dam A
- Subjects
- Adult, Antibodies, Monoclonal immunology, Antibodies, Monoclonal, Murine-Derived immunology, Antibody Specificity, Biomarkers, Deglutition Disorders etiology, Epidermal Cyst diagnostic imaging, Epidermal Cyst epidemiology, Epidermal Cyst metabolism, Epidermal Cyst pathology, Epidermal Cyst surgery, Humans, Immunoenzyme Techniques, Magnetic Resonance Imaging, Male, Membrane Glycoproteins immunology, Mouth Diseases diagnostic imaging, Mouth Diseases metabolism, Mouth Diseases pathology, Mouth Diseases surgery, Mouth Floor, Radiography, Snoring etiology, Epidermal Cyst diagnosis, Membrane Glycoproteins analysis, Mouth Diseases diagnosis
- Abstract
Aim: We present the case of a surgically treated 39-year-old man with diagnosis of a giant sublingual internal epidermoid cyst. Usually, such dermoid or epidermoid cysts are caused by aberrant ectodermal tissues or by acquired aberrant epithelial tissues arising from the foetal period, or from trauma or surgery. The incidence of oral dermoid or epidermoid cysts is about 1.6%; most occur at the mouth floor but they nevertheless are very rare., Case Report: The patient presented with a history of progressive swelling of the sublingual region with dysphagia, progressive snoring during sleep and occasional shortness of breath. The suspected clinical diagnosis of a giant sublingual dermoid or epidermoid cyst was supported by the radiological finding after performing magnetic resonance imaging. The cyst was surgically removed under general anaesthesia through an intraoral approach. The immunohistological analysis of the specimen with a monoclonal antibody against podoplanin (D2-40) showed a positive reaction in the basal epithelial layer, exclusively in areas with secondary inflammation, but not in the remaining cyst wall., Conclusion: Sublingually situated extensive epidermoid cysts are rare findings in the oral cavity. In such cases, surgical excision remains the only treatment. We demonstrated that cystic epithelia were normally not immunoreactive for D2-40 but strong immunoreactivity was observed in the basal epithelial cell layer, in areas of ruptured cyst wall associated with secondary inflammatory changes.
- Published
- 2012
50. Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors.
- Author
-
Blessmann M, Gröbe A, Quaas A, Kaifi JT, Mistakidis G, Bernreuther C, Sauter G, Gros S, Rawnaq T, Friedrich R, Mautner VF, Smeets R, Heiland M, Schachner M, and Izbicki JR
- Subjects
- Adolescent, Adult, Aged, Cell Transformation, Neoplastic metabolism, Child, Child, Preschool, Female, Humans, Immunohistochemistry, Infant, Male, Mast Cells metabolism, Middle Aged, Nerve Sheath Neoplasms genetics, Neural Cell Adhesion Molecule L1 genetics, Neurofibroma genetics, Neurofibromatosis 1 genetics, Neurofibromatosis 1 metabolism, Retrospective Studies, Young Adult, Cell Transformation, Neoplastic genetics, Gene Expression Regulation, Neoplastic physiology, Nerve Sheath Neoplasms metabolism, Neural Cell Adhesion Molecule L1 metabolism, Neurofibroma metabolism
- Abstract
Type 1 neurofibromatosis (NF-1), also known as von Recklinghausen disease, is caused by a disorder of a single gene on chromosome 17 that usually restrains cell division. A sequence that is frequently associated with NF-1 is tumor progression from neurofibromas to malignant peripheral nerve sheath tumors (MPNSTs). The aim of this study was to determine the expression of the neural L1 cell adhesion molecule in dermal-diffuse neurofibromas, plexiform neurofibromas, and MPNSTs of NF-1. We retrospectively analyzed surgically resected primary tumors, including 20 dermal neurofibromas, 23 plexiform neurofibromas, and 17 MPNSTs, by immunohistochemistry in paraffin sections of NF-1 tumors with the use of the L1-specific monoclonal antibody UJ127, which does not cross-react with other members of the L1 family. Immunostainings for CD34 and S100 were included to distinguish and allocate L1-expressing Schwann cells and perineural (specialized) fibroblasts. Our data showed that L1 is highly expressed in all benign NF-1 tumors and in some but not all MPNSTs. Furthermore, we demonstrated a correlation between L1 expression and differentiation grade of MPNSTs. There was a significant trend toward lower or nondetectable expression in the poorly differentiated MPNSTs, in contrast to all other tumor entities so far investigated, in which L1 expression correlated positive with malignancy, except for juvenile but not adult-derived neuroblastomas. Future studies are warranted to elucidate the molecular basis of the varying effects of the degree of L1 expression, receptor, and signal transduction mechanisms in different tumors., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.